ANN ARBOR, MI -- (MARKET WIRE) -- April 18, 2007 -- Pipex Pharmaceuticals, Inc. (OTCBB: PPXP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of neurologic and fibrotic diseases, announced today that it has appointed Dr. Kay E. Stremler as Vice President of Manufacturing.
